CG Oncology (CGON) Total Liabilities (2023 - 2026)

CG Oncology (CGON) has 4 years of Total Liabilities data on file, last reported at $43.5 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities rose 85.64% year-over-year to $43.5 million; the trailing twelve-month figure through Mar 2026 stood at $43.5 million (up 85.64% YoY), and the FY2025 full-year result was $39.0 million, up 82.03% from the prior year.
• Total Liabilities for Q1 2026 stood at $43.5 million, up from $39.0 million in the prior quarter.
• Across five years, Total Liabilities topped out at $107.6 million in Q3 2023 and bottomed at $10.2 million in Q1 2024.
• The 4-year median for Total Liabilities is $31.1 million (2025), against an average of $41.9 million.
• The widest annual swing landed in 2024, when Total Liabilities plunged 88.19%; it then jumped 169.22% in 2025.
• A 4-year view of Total Liabilities shows it stood at $14.5 million in 2023, then soared by 47.61% to $21.4 million in 2024, then jumped by 82.03% to $39.0 million in 2025, then rose by 11.52% to $43.5 million in 2026.
• The last three Total Liabilities figures came in at $43.5 million (Q1 2026), $39.0 million (Q4 2025), and $42.3 million (Q3 2025), per Business Quant data.

Peer Comparison